These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7718093)

  • 1. Immunotherapy for recurrent miscarriage.
    Coulam CB; Clark DA
    Am J Reprod Immunol; 1994 Dec; 32(4):257-60. PubMed ID: 7718093
    [No Abstract]   [Full Text] [Related]  

  • 2. Implication of abnormal human trophoblast karyotype for the evidence-based approach to the understanding, investigation, and treatment of recurrent spontaneous abortion. The Recurrent Miscarriage Immunotherapy Trialists Group.
    Clark DA; Daya S; Coulam CB; Gunby J
    Am J Reprod Immunol; 1996 May; 35(5):495-8. PubMed ID: 8738721
    [No Abstract]   [Full Text] [Related]  

  • 3. Soluble interleukin-2 receptors in recurrent miscarriage and the effect of leukocyte immunotherapy.
    Kilpatrick DC
    Immunol Lett; 1992 Dec; 34(3):201-6. PubMed ID: 1487306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Prepregnancy Lymphocyte Active Immunotherapy on Unexplained Recurrent Miscarriage, Pregnancy Success Rate, and Maternal-Infant Outcome.
    Li J; Gu Y; Zhang S; Ju B; Wang J
    Biomed Res Int; 2021; 2021():7878752. PubMed ID: 34692842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infertility treated with donor specific lymphocytes in recurrent idiopathic spontaneous abortion.
    Bernstein IL; Bernstein DI; Balakrishnan K; Korbee L
    Transplant Proc; 1989 Feb; 21(1 Pt 1):565. PubMed ID: 2705234
    [No Abstract]   [Full Text] [Related]  

  • 6. The effectiveness of allogeneic leukocyte immunization in unexplained primary recurrent spontaneous abortion. Recurrent Miscarriage Immunotherapy Trialists Group.
    Daya S; Gunby J
    Am J Reprod Immunol; 1994 Dec; 32(4):294-302. PubMed ID: 7718097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunotherapy in patients with habitual spontaneous miscarriage].
    Minon JM; Pirenne H; Bouillenne C; Gaspard U; Cusumano G; Frère MC
    Rev Med Liege; 1989 Feb; 44(4):149-59. PubMed ID: 2523084
    [No Abstract]   [Full Text] [Related]  

  • 8. Remote pregnancy outcome after leukocyte immunotherapy.
    Kilpatrick DC; Liston WA
    Fertil Steril; 1994 Aug; 62(2):409-11. PubMed ID: 8034093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential alloimmune factors and immunotherapy in recurrent miscarriage.
    Scott JR; Branch DW
    Clin Obstet Gynecol; 1994 Sep; 37(3):761-7. PubMed ID: 7955659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neonatal thrombocytopenia as side effect of immunotherapy for recurrent spontaneous abortion.
    Deligiannidis A; Parapanissiou E; Mavroudi A; Papastavrou T
    Am J Reprod Immunol; 2007 Mar; 57(3):167-8. PubMed ID: 17295894
    [No Abstract]   [Full Text] [Related]  

  • 11. Intravenous immune globulin in recurrent abortion.
    Heine O; Mueller-Eckhardt G
    Clin Exp Immunol; 1994 Jul; 97 Suppl 1(Suppl 1):39-42. PubMed ID: 8033433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcome of pregnancy in women with recurrent spontaneous abortion following immunotherapy with allogeneic lymphocytes.
    Agrawal S; Kishore R; Halder A; Sharma A; Sharma RK; Das V; Shukla BR; Agarwal SS
    Hum Reprod; 1995 Sep; 10(9):2280-4. PubMed ID: 8530652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy and recurrent abortion: a randomized clinical trial.
    Illeni MT; Marelli G; Parazzini F; Acaia B; Bocciolone L; Bontempelli M; Faden D; Fedele L; Maffeis A; Radici E
    Hum Reprod; 1994 Jul; 9(7):1247-9. PubMed ID: 7962426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A feasibility trial of screening women with idiopathic recurrent miscarriage for high uterine natural killer cell density and randomizing to prednisolone or placebo when pregnant.
    Tang AW; Alfirevic Z; Turner MA; Drury JA; Small R; Quenby S
    Hum Reprod; 2013 Jul; 28(7):1743-52. PubMed ID: 23585559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA frequency, HLA sharing and immunotherapy in the management of recurrent miscarriage.
    Purandare AS; Smith DS; Wilson PJ
    Int J Fertil Menopausal Stud; 1993; 38(4):219-24. PubMed ID: 8401680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does immunotherapy for treatment of reproductive failure enhance live births?
    Coulam CB; Acacio B
    Am J Reprod Immunol; 2012 Apr; 67(4):296-304. PubMed ID: 22340745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors associated with a new pregnancy loss and perinatal outcomes in cases of recurrent miscarriage treated with lymphocyte immunotherapy.
    Cavalcante MB; Costa Fda S; Araujo Júnior E; Barini R
    J Matern Fetal Neonatal Med; 2015 Jun; 28(9):1082-6. PubMed ID: 25005857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy for recurrent miscarriage. Consensus conference. Washington, D.C., July 16-17, 1993.
    Am J Reprod Immunol; 1994 Dec; 32(4):257-302. PubMed ID: 7718092
    [No Abstract]   [Full Text] [Related]  

  • 19. The expression of Th1- and Th2-related chemokine receptors in women with recurrent miscarriage: the impact of lymphocyte immunotherapy.
    Kheshtchin N; Gharagozloo M; Andalib A; Ghahiri A; Maracy MR; Rezaei A
    Am J Reprod Immunol; 2010 Aug; 64(2):104-12. PubMed ID: 20331585
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Obstetrical immunology. 7. Incompatibility and immunity: with special reference to immunotherapy in habitual abortion].
    Takeuchi S; Takakuwa K
    Josanpu Zasshi; 1987 Oct; 41(10):888-91. PubMed ID: 3682312
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.